Chest complaints more costly in obese patients

Chest complaints more costly in obese patients

(HealthDay)—Higher body mass index (BMI) is associated with increased cost of care and longer hospital stays for patients who present to the emergency department with chest pain and dyspnea, according to research published online March 4 in Circulation: Cardiovascular Quality and Outcomes.

Geoffrey W. Peitz, of the Indiana University School of Medicine in Indianapolis, and colleagues prospectively analyzed costs and outcomes stratified by BMI for patients presenting to the with and dyspnea.

The researchers found that costs of care were 41 percent higher for morbidly (P = 0.015), 28 percent higher for obese patients (P = 0.020), and 22 percent higher for (P = 0.077), than for normal-weight patients. Compared with normal-weight patients, morbidly obese patients had longer lengths of hospital stay with or without computed tomography (CT) scanning (44 percent longer with CT [P = 0.083]; 34 percent longer without CT [P = 0.073]). Morbidly obese patients had the highest rate (87 percent) of no significant cardiopulmonary diagnosis for 90 days after CT pulmonary angiography.

"These findings substantiate the need for clinical protocols that reduce overuse of imaging in patients with high BMI and chest complaints," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Chest pain duration can signal heart attack

Sep 11, 2013

Patients with longer-lasting chest pain are more likely having a heart attack than those with pain of a shorter duration, according to a study by researchers at Henry Ford Hospital.

Recommended for you

Appropriate use criteria established for pediatric ECHO

2 hours ago

(HealthDay)—Appropriate use criteria have been developed for the initial use of transthoracic echocardiography in outpatient pediatric cardiology. The guidelines were published online Sept. 29 in the Journal of ...

Fish oil supplements don't prevent recurrence of A-fib

Sep 30, 2014

(HealthDay)—High doses of fish oil supplements won't prevent recurrence of atrial fibrillation (AF), Canadian researchers report. The study, funded by the Canadian Institutes for Health Research and the ...

User comments